scholarly journals The roles of Na+/H+ exchanger regulatory factor 1 and aquaporin-1 in the pathomechanism of experimental acute pancreatitis

2019 ◽  
Author(s):  
Zsolt Balla

Introduction: Pancreatic ductal epithelial cells (PDEC) secrete an alkaline HCO_3^- rich isotonic fluid. The secretion of HCO_3^- across the apical membrane of PDEC is mediated by cystic fibrosis transmembrane conductance regulator Cl- channel (CFTR) and solute carrier family 26 (SLC26) anion exchangers. Na+/H+ exchanger regulatory factor isoform 1 (NHERF 1) is a cytosolic adaptor protein, which binds CFTR on the apical membrane of epithelial cells. Aquaporins (AQPs) facilitate the transepithelial water flow involved in epithelial fluid secretion in numerous tissues. Acute pancreatitis (AP) is a serious disorder in which specific treatment is still not possible. Accumulating evidence indicate that decreased pancreatic ductal fluid secretion plays an essential role in AP. The role of NHERF-1 in the pancreas has not yet been investigated despite the fact that CFTR, a key regulator of epithelial function, is controlled by this scaffolding protein Also the functions of AQPs in the pancreas are less characterized. Our aim was to characterize the function of NHERF-1 and AQP1 in AP. Methods: We used 12 16 week old WT, NHERF 1 knock-out (KO) and AQP1 KO male mice. In the AP groups, mice were injected 7 or 10 times hourly, intraperitoneally (i.p.) with 50 µg/kg cerulein. In another AP model, 4 % Na taurocholate was administered i.d. via the punctured duodenum. Control animals were injected i.p. or i.d. with PS instead of cerulein or Na taurocholate (n=6-8). Animals were sacrificed at 12 hours in case of the cerulein model or 24 hours in the Na taurocholate experiment. Laboratory [serum amylase or, pancreatic myeloperoxidase (MPO) activity, pancreatic IL 1β concentrations] and histological parameters (pancreatic necrosis, edema, inflammatory cell infiltration) were measured to evaluate disease severity. Expression of HSP 72, IκB α, and IκB β contents were determined by Western blot analysis. Our results showed that the induction of AP was successful in both models and also in both strains. The injection of mice with cerulein or Na taurocholate increased the measured laboratory and histological parameters vs. the control groups. The measured laboratory (serum amylase, HSP72) and histological parameters (necrosis, apoptosis) were significantly elevated in AP mice injected with cerulein vs. control mice. In accord with the measured pancreatic MPO , trypsinogen activity, IκB α, IκB β, or pancreatic IL 1β concentrations were not significantly altered in the NHERF 1 KO group vs. the WT AP groups. In case of the Na taurocholate-induced AP, pancreatic necrosis, hemorrhage and MPO activity were significantly increased in the NHERF 1 KO group vs. the WT AP group. However, the pancreatic edema, leukocyte infiltration, IL 1β concentrations and serum amylase activity were significantly elevated in the WT or NHERF 1 KO AP vs. respective control groups but not in the NHERF 1 KO vs WT AP groups. The pancreatic leukocyte infiltration, edema, necrosis or serum amylase activity were significantly increased in cerulein-treated vs. control groups. In accord with the histological results, only necrosis and serum amylase activity were increased significantly in the AQP1 KO vs. WT AP groups. In conclusion, after complete evaluation of the data, we can say that the AP in both NHERF 1 or AQP1 KO groups were more severe. These results may be due the reduced HCO_3^- and fluid secretion.

1978 ◽  
Vol 24 (5) ◽  
pp. 815-820 ◽  

Abstract This case focuses on the biochemical findings in acute pancreatitis and the role of the laboratory in the diagnosis and management of such patients. It also illustrates a major unappreciated problem in the use of amylase determinations in patients with acute pancreatitis: normal serum amylase activity in the presence of hyperlipemia.


PEDIATRICS ◽  
1983 ◽  
Vol 71 (4) ◽  
pp. 585-587
Author(s):  
Jacques Belik ◽  
Carl Tishler ◽  
Juhling McClung

A patient with recurrent vomiting, abdominal pain, and elevated serum amylase activity may have pancreatitis. Although elevated serum amylase levels are a sensitive indicator for acute pancreatitis, this test is not highly specific for pancreatic disease. A patient is described who illustrates the need for specific laboratory, historical, and occasional psychological evaluation in pediatric patients with elevated amylase values.


1970 ◽  
Vol 16 (12) ◽  
pp. 985-989 ◽  
Author(s):  
Wendell R O'Neal ◽  
Nathan Gochman

Abstract An automated adaptation of the Somogyi saccharogenic determination of serum amylase is described in which conventional AutoAnalyzer modules are used. Adequate sensitivity with short incubation is achieved by incorporating glucose oxidase and catalase in the substrate to destroy serum glucose during incubation. Maltose and other dialyzable oligosaccharides are measured with the alkaline copper-neocuproine reaction. A simultaneous blank run is performed to determine reducing substances other than glucose in serum. Precision studies and correlation with a manual saccharogenic method are presented. The normal range was determined from data for 49 healthy blood donors.


1970 ◽  
Vol 16 (4) ◽  
pp. 300-304 ◽  
Author(s):  
Klaus Lorentz ◽  
Detlef Oltmanns

Abstract To determine serum amylase activity we have quantitatively measured the glucose and maltose hydrolyzed from soluble starch by colorimetrically measuring the reduction of colorless triphenyltetrazolium chloride to a red formazan, which is dissolved in methanol. The method is suitable for use with microsamples of all biological fluids, and is specific for the final products of starch digestion. Values found for sera from 55 apparently healthy blood donors ranged from 0.15 to 1.55 (mean, 0.83; standard deviation, ±0.4) mg of glucose per ml per h, corresponding to 7.5 to 78 Somogyi units.


2006 ◽  
Vol 1 (4) ◽  
pp. 260-267 ◽  
Author(s):  
R. B. Kalahasthi ◽  
Rajmohan Hirehal Raghavendra Rao ◽  
Rajan Bagalur Krishna Murthy ◽  
M. Karuna Kumar

2007 ◽  
Vol 53 (12) ◽  
pp. 2105-2111 ◽  
Author(s):  
David Schmidt ◽  
Stephen O Brennan

Abstract Background: During an investigation of genetic variants of fibrinogen, we observed a novel form of the Bβ chain, with a mass decrease of approximately 128 Da, in one of the controls. The plasma sample originated from an individual who had experienced acute pancreatitis a week earlier but whose serum amylase activity had returned to normal. We investigated the structure of the modified fibrinogen and explored its relationship to pancreatic disease. Method: Fibrinogen was isolated from the plasma of 9 individuals with increased pancreatic amylase activity (114–1826 U/L) and presumed pancreatitis and from 6 control individuals with amylase activities <56 U/L. Fibrinogen (or fibrin) Bβ chains were isolated by reversed-phase HPLC and analyzed directly by electrospray ionization mass spectrometry. Tryptic and CNBr peptide mapping and thrombin treatment pinpointed the location of the 128-Da loss in mass. Results: The acquired fibrinogen Bβ chain modification was attributable to the loss of its C-terminal glutamine residue. Incubating purified fibrinogen with pancreatic carboxypeptidase A (CpA) produced an identical modification. The des-Gln Bβ fibrinogen accounted for >80% of the Bβ chains in 3 of the individuals with increased amylase but only approximately 5% of the Bβ chains in control samples. Conclusion: Pancreatic CpA activity is used as an index of acute pancreatic disease, but given that the circulatory half-lives of fibrinogen and CpA are approximately 4 days and only 2.5 h, respectively, measuring des-Gln Bβ fibrinogen, the in vivo product of CpA activity, could provide clinicians with retrospective evidence of disease.


2008 ◽  
Vol 90 (2) ◽  
pp. 393-400
Author(s):  
Ravi Babu Kalahasthi ◽  
Rajmohan Hirehal Raghavendra Rao ◽  
Rajan Bagalur Krishna Murthy ◽  
M. Karuna Kumar

Sign in / Sign up

Export Citation Format

Share Document